Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FZ847
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,920
Award facts
- Contract value 100% obligated
- $16,919.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $16,919.57 delivery order to Amerisourcebergen Drug Corp on June 11, 2026, for RINVOQ ER 15 mg tablets (30-count unit of use).
Place of performance is Conshohocken, PA. Ultimate completion date is June 12, 2026. This is a firm fixed-price delivery order with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor and medical supplier to the Department of Defense and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FZ847?
SPE2DR26FZ847 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 11, 2026.
How much is contract SPE2DR26FZ847 worth?
The government has obligated $16,920 on SPE2DR26FZ847.
Is contract SPE2DR26FZ847 an order under another contract?
Yes. SPE2DR26FZ847 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FZ847 competed?
The extent of competition for SPE2DR26FZ847 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award